These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11901301)

  • 1. Desensitization of alpha(2)-adrenoceptors which regulate noradrenaline synthesis and release after chronic treatment with clorgyline in the rat brain.
    Prieto M; Giralt MT
    Pharmacology; 2002 May; 65(1):49-56. PubMed ID: 11901301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain.
    Prieto M; Giralt MT
    Pharmacol Toxicol; 2001 Mar; 88(3):152-8. PubMed ID: 11245411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute, repeated and chronic variable stress on in vivo tyrosine hydroxylase activity and on alpha(2)-adrenoceptor sensitivity in the rat brain.
    Prieto M; Gómez FM; Teresa Giralt M
    Stress; 2003 Dec; 6(4):281-7. PubMed ID: 14660060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilocarpine treatments differentially affect alpha2-adrenoceptors which modulate the firing rate of locus coeruleus neurones and the synthesis and release of noradrenaline in rat brain.
    Garro MA; Pineda J; Giralt MT; Ugedo L
    Pharmacol Toxicol; 1999 Aug; 85(2):74-9. PubMed ID: 10488688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors.
    Sacchetti G; Bernini M; Gobbi M; Parini S; Pirona L; Mennini T; Samanin R
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):66-72. PubMed ID: 11191838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study.
    Mateo Y; Fernández-Pastor B; Meana JJ
    Br J Pharmacol; 2001 Aug; 133(8):1362-70. PubMed ID: 11498523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes.
    Esteban S; Lladó J; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):391-9. PubMed ID: 8935705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antidepressant drugs on monoamine synthesis in brain in vivo.
    Moret C; Briley M
    Neuropharmacology; 1992 Jul; 31(7):679-84. PubMed ID: 1357575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic clorgyline induces selective down-regulation of alpha2-adrenoceptor agonist binding sites in rat brain.
    Miralles A; Ribas C; Escribá PV; García-Sevilla JA
    Pharmacol Toxicol; 2000 Dec; 87(6):269-75. PubMed ID: 11140825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2-autoreceptor-mediated modulation of tyrosine hydroxylase activity in noradrenergic regions of the rat brain in vivo.
    Pi F; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):653-60. PubMed ID: 1353254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of 3,4-methylenedioximethamphetamine on noradrenergic activity in locus coeruleus and hippocampus of the rat.
    Arrue A; Ruiz-Ortega JA; Ugedo L; Giralt MT
    Neurosci Lett; 2003 Feb; 337(3):123-6. PubMed ID: 12536039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex.
    Finberg JP; Pacak K; Kopin IJ; Goldstein DS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):500-5. PubMed ID: 8391652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: effects of antidepressant drugs.
    Ellison DW; Campbell IC
    J Neurochem; 1986 Jan; 46(1):218-23. PubMed ID: 2415679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.
    Hovevey-Sion D; Finberg JP
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):70-6. PubMed ID: 3114651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]adrenaline release from hypothalamic synaptosomes and its modulation by clonidine: effects of chronic antidepressant drug regimens.
    McWilliam JR; Campbell IC
    Life Sci; 1987 Jul; 41(2):145-52. PubMed ID: 3037219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term regulation of brain alpha 2-adrenoceptors after manipulation of noradrenergic transmission in the rat.
    Giralt MT; García-Sevilla JA
    Eur J Pharmacol; 1989 May; 164(3):455-66. PubMed ID: 2569977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antidepressant drug treatments on alpha 2-adrenoceptor control of [3H]noradrenaline release from hypothalamic synaptosomes.
    McWilliam JR; Campbell IC
    J Neurochem; 1987 Jul; 49(1):163-8. PubMed ID: 3035092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "In vitro" effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system.
    Morón JA; Perez V; Fernández-Alvarez E; Marco JL; Unzeta M
    J Neural Transm Suppl; 1998; 52():343-9. PubMed ID: 9564637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.
    Ribas C; Miralles A; Busquets X; García-Sevilla JA
    Br J Pharmacol; 2001 Apr; 132(7):1467-76. PubMed ID: 11264240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.